Vascular Biology Symposium, May 22

On May 22 a half-day symposium on vascular biology will be arranged at the Rudbeck Laboratory....

6th Uppsala-Hallym symposium: Stem Cells and Regenerative Medicine

On May 23, the 6th Uppsala-Hallym symposium is arranged at the Rudbeck Laboratory. The focus of this one-day symposium is stem cells and regenerative medicine....

Apply for our Master programmes

Late applications accepted by Swedish students and students who are EU/EEA citizens from July 15th 2014.

Master programme in Molecular Medicine

Master programme i Forensic Science



Up-coming thesis defences at IGP

  • Friday, April 25, 2014 13:00 B21, Biomedicinskt centrum, Husargatan 3, SE-75123, Uppsala Wu, Di Proximity Ligation and Barcoding Assays: Tools for analysis of proteins and protein complexes. Download fulltext More information
  • Saturday, May 10, 2014 09:15 Sal X, Universitetshuset, Biskopsgatan 3, Uppsala Berglund, David Preparatory Studies to Introduce Regulatory T Cells in Clinical Transplantation. Download fulltext More information

Exterior BMC and Rudbeck Lab

Welcome to IGP

The department conducts advanced research and education in areas such as clinical immunology, medical and clinical genetics, pathology, tumor biology and vascular biology. Part of the work is done in collaboration with the units of clinical genetics, clinical pathology and clinical immunology at Uppsala University Hospital.

Clinical genetics
Clinical pathology
Clinical immunology and transfusion medicine


New research findings from IGP

New substance identified that kills brain tumour cells

Glioblastoma is the most severe form of brain tumour. Researchers at IGP have together with scientists at Karolinska Institutet identified a substance that selectively kills glioblastoma cells and which could be used to develop a new therapy. The study has recently been published in the scientific journal Cell.

New type of cell communication regulates blood vessel formation and tumour growth

When tumours grow, new blood vessels are formed that deliver oxygen and nutrients to the tumour cells. Lena Claesson-Welsh’s research group at IGP has discovered a new type of cell communication that results in suppressed blood vessel formation and delayed tumour growth. The results might explain why healthy individuals can have microscopic tumours for many years, which do not progress without formation of new blood vessels. The study has recently been published in the journal Developmental Cell.

Smoking changes our genes

The fact that smoking means a considerable health risk is nowadays commonly accepted. New research findings from IGP and Uppsala Clinical Research Center show that smoking alters several genes that can be associated with health problems for smokers, such as increased risk for cancer and diabetes.


Göran Gustafsson prize to Sara Mangsbo

Sara Mangsbo har recently been awarded the Göran Gustafsson Prize for young researchers.

IGP researchers receive two out of four grants from BIO-X

Peetra Magnusson and Sara Mangsbo have both been granted funding from the BIO-X programme. The grants include a financial support of two million SEK and the researchers are offered process support, coaching and reviewing during two years.

Fredrik Swartling receives Young Investigator Award

The Swedish Cancer Society has decided to grant Fredrik Swartling a Young Investigator Award. This means that he will get a researcher position financed during six years.